Intellia Therapeutics NTLA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's operating lease right-of-use assets in other assets?
- Intellia Therapeutics (NTLA) reported operating lease right-of-use assets in other assets of $97.54M in Q1 2026.
- How has Intellia Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Intellia Therapeutics's operating lease right-of-use assets in other assets decreased by 29.3% year-over-year, from $137.98M to $97.54M.
- What is the long-term trend for Intellia Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Intellia Therapeutics's operating lease right-of-use assets in other assets has grown at a 22.1% compound annual growth rate (CAGR), from $39.11M to $105.96M.